Released: · Last reviewed:
Brand-name semaglutide (Wegovy, Ozempic) ranges from $999 (Ozempic retail) to $1,059 (Wegovy retail) per month, with NovoCare direct-to-consumer pricing at $349-$549 depending on dose. Compounded semaglutide ranges from $49–$179 a month across the 23 programs in our November 2026 index depending on provider and plan length.
NexLife's 12-month plan totals $1,140 ($95 a month) vs. brand-name retail of approximately $12,000-$12,700/year. HSA and FSA accounts can be used. Insurance generally does not cover compounded GLP-1 medications.
NexLife is structured around clinical best practices for semaglutide. See full NexLife review.
Compounded semaglutide · clinician oversight
*12-month plan · flat rate · all titration doses
Or call (949) 818-8000
Citations supporting clinical and regulatory statements on this page. External links open in a new tab.